EVOLUTION OF ANDROGEN DEPRIVATION THERAPY

被引:0
|
作者
Raj, Ganesh V. [1 ]
Selth, Luke A. [2 ,3 ]
Day, Tanya K. [2 ,3 ]
Tilley, Wayne D. [2 ,3 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[2] Univ Adelaide, Dame Roma Mitchell Canc Res Labs, Discipline Med, Adelaide, SA 5005, Australia
[3] Univ Adelaide, Sch Med, Freemasons Fdn Ctr Mens Hlth, Adelaide, SA 5005, Australia
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The androgen signalling axis is critical for the development and progression of prostate cancer. Therefore, the mainstay treatments for metastatic disease are hormonal manipulations aimed at reducing androgen levels and/or blocking the androgen receptor, collectively termed androgen deprivation therapy. This review will discuss the evolution of androgen deprivation therapy since it was instigated more than 70 years ago, and outline the key mechanisms underlying its inevitable failure. We will also briefly introduce potential new androgen signalling-targeted therapies in clinical development.
引用
下载
收藏
页码:189 / 194
页数:6
相关论文
共 50 条
  • [1] Androgen Deprivation Therapy for Advanced Prostate Cancer: Can Evolution Be Accelerated?
    Mohler, James L.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (06): : 701 - 703
  • [2] Androgen deprivation therapy complications
    Allan, Carolyn A.
    Collins, Veronica R.
    Frydenberg, Mark
    McLachlan, Robert I.
    Matthiesson, Kati L.
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : T119 - T129
  • [3] Osteoporosis and androgen deprivation therapy
    Adami, S
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S21 - S21
  • [4] Metformin and Androgen Deprivation Therapy
    Hsu, Chen-Xiong
    Shueng, Pei-Wei
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 116 (03): : 694 - 694
  • [5] Androgen deprivation and radiation therapy
    McKenzie, MR
    UROLOGY, 1996, 47 (02) : 286 - 286
  • [6] Androgen deprivation therapy and risk of diabetes mellitus in men undergoing androgen deprivation therapy for prostate cancer
    Kincade, MC
    Derweesh, IH
    Malcolm, J
    Lamar, KD
    Patterson, AL
    Kitabchi, AE
    Wake, R
    JOURNAL OF UROLOGY, 2006, 175 (04): : 41 - 41
  • [8] CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
    Boban, Marko
    ACTA CLINICA CROATICA, 2019, 58 (01) : 60 - 63
  • [9] Androgen deprivation therapy and BMD loss
    Katherine Sole
    Nature Clinical Practice Oncology, 2006, 3 (3): : 123 - 123
  • [10] Optimizing the duration of androgen deprivation therapy
    Eric M. Horwitz
    Nature Reviews Urology, 2009, 6 : 527 - 529